These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15907917)

  • 1. Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology.
    Silman I; Sussman JL
    Curr Opin Pharmacol; 2005 Jun; 5(3):293-302. PubMed ID: 15907917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholinesterase function is dispensable for sensory neurite growth but is critical for neuromuscular synapse stability.
    Downes GB; Granato M
    Dev Biol; 2004 Jun; 270(1):232-45. PubMed ID: 15136152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The fasciculin-acetylcholinesterase interaction].
    Marchot P
    J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody against synaptic AChE: a useful tool for detecting apoptotic cells.
    Su W; Wu J; Ye WY; Zhang XJ
    Chem Biol Interact; 2008 Sep; 175(1-3):101-7. PubMed ID: 18538755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
    Kapková P; Stiefl N; Sürig U; Engels B; Baumann K; Holzgrabe U
    Arch Pharm (Weinheim); 2003 Nov; 336(11):523-40. PubMed ID: 14639745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.
    Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A
    J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission.
    Zimmerman G; Soreq H
    Cell Tissue Res; 2006 Nov; 326(2):655-69. PubMed ID: 16802134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues.
    Zhou X; Wang XB; Wang T; Kong LY
    Bioorg Med Chem; 2008 Sep; 16(17):8011-21. PubMed ID: 18701305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ
    J Med Chem; 2008 Jun; 51(12):3588-98. PubMed ID: 18517184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-sense approach to anticholinesterase therapeutics.
    Soreq H; Seidman S
    Isr Med Assoc J; 2000 Jul; 2 Suppl():81-5. PubMed ID: 10909423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
    Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
    J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates.
    Fang L; Kraus B; Lehmann J; Heilmann J; Zhang Y; Decker M
    Bioorg Med Chem Lett; 2008 May; 18(9):2905-9. PubMed ID: 18406135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective enhancement of the activity of C-terminally truncated, but not intact, acetylcholinesterase.
    Zimmermann M; Grösgen S; Westwell MS; Greenfield SA
    J Neurochem; 2008 Jan; 104(1):221-32. PubMed ID: 17986217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
    Tumiatti V; Milelli A; Minarini A; Rosini M; Bolognesi ML; Micco M; Andrisano V; Bartolini M; Mancini F; Recanatini M; Cavalli A; Melchiorre C
    J Med Chem; 2008 Nov; 51(22):7308-12. PubMed ID: 18954037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adhesion function on acetylcholinesterase is located at the peripheral anionic site.
    Johnson G; Moore SW
    Biochem Biophys Res Commun; 1999 May; 258(3):758-62. PubMed ID: 10329459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
    Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
    J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
    Xie Q; Wang H; Xia Z; Lu M; Zhang W; Wang X; Fu W; Tang Y; Sheng W; Li W; Zhou W; Zhu X; Qiu Z; Chen H
    J Med Chem; 2008 Apr; 51(7):2027-36. PubMed ID: 18333606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.
    Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J
    Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.